Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days

Transplantation

Volumn 70, Issue 7, 2000, Pages 989-998

  Ramirez, P ^a   Chavez, R ^b   Majado, M ^a   Munitiz, V ^a   Munoz A ^c   Hernandez, Q ^a   G Palenciano, C ^a   Pino Chavez, G ^d   Loba, M ^a   Minguela, A ^a   Yelamos, J ^a   Gago, M R ^a   Vizcaino, A S ^a   Asensi, H ^a   Cayuela, M G ^a   Segura, B ^a   Marin, F ^a   Rubio, A ^a   Fuente, T ^a   Robles, R ^a   Bueno, F S ^a   Sansano, T ^a   Acosta, F ^a   Rodriguez, J M ^a   Navarro, F ^e   Cabezuelo, J ^a   Cozzi, E ^d,e,f   White, D J G ^d,e,f   Calne, R Y ^f   Parrilla, P ^a   more..

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c UNIVERSITY OF MURCIA   (Spain)

^d Imutran Limited   (United Kingdom)

^e UNIV MONTPELLIER   (France)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; FIBRINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; GRAFT REJECTION; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SWINE; TRANSGENIC ANIMAL; XENOTRANSPLANTATION;

EID: 0034668088     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200010150-00001     Document Type: Article

References (40)

1. Introduction
2. The pig as potential organ donor for man
3. The pig as a potential organ donor for a man: A study of potentially transferable disease from donor pig to recipient man
4. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue
5. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors
6. Orthotopic heart transplantation in a transgenic pig-to-primate model
7. Discordant organ xenotransplantation in primates: World experience and current status
8. Pig to baboon liver xenografts
9. Porcine to primate orthotopic liver transplantation
10. Immunohistopathologic lesions associated with the rejection of a pig to human liver xenograft
11. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants
12. Surgical procedure for specific pathogen free piglet production by modified terminal hysterectomy
13. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man
14. Characterisation of pigs transgenic for human decay accelerating factor
15. Experimental concordant liver xenotransplantation in non-human primates
16. Antibody depletion prolongs xenograft survival
17. Normal Coagulation Parameters after pig livers and kidneys perfusion with human plasma, intended to xenoantibodies depletion
18. Inmunologia practica
19. Study of xenograft rejection in a model of liver xenotransplantation from unmodified pig to primate
20. Hepatic allografts and xenografts in primates
21. Comparative histopathology of hepatic allografts and xenografts in the nonhuman primates
22. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients
23. Effect of preservation time on early graft function and outcome of orthotopic liver transplants
24. Regulation of the complement cascade by soluble complement receptor type I. Protective effect in experimental liver ischaemia and reperfusion
25. Time course of complement activation and inhibitor expression after ischaemic injury of rat myocardium
26. The generation of transgenic pigs as potential organ donors for humans
27. Effect of transgenic expression of human decay accelerating factor on the inhibition of hyperacute rejection of pig organs
28. Early recipient-donor switch of the complement type after liver xenotransplantation
29. Hamster coagulation and serum protein in rat recipients of hamster xenografts
30. Hemostasis (chapter 10). (Appendix 8, Blood analysis reference values in large animals)
31. Comparison of bile chemistry between humans, baboons, and pigs: Implictions for clinical and experimental liver xenotransplantation
32. Hematological and hepatic function profile comparison between pig and baboon in an orthotopic liver xenotransplantation model
33. Characterization of the acute phase serum protein response in pigs
34. Baboon-to-human liver transplantation
35. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts
36. Xenotransplantation. Time to leave the laboratory
37. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: Clinical results and lack of pig-to-human transmission of the porcine endogenous retroviirus
38. Classification, etiology and considerations of outcome in acute liver failure
39. Continuous veno-venous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting. Bridge to liver transplantation